Package 49483-690-04

{"route": ["ORAL"], "spl_id": "c715d9f2-9fe1-0bdd-e053-2a95a90aecf2", "openfda": {"upc": ["0349483691047", "0349483691504", "0349483690040"], "unii": ["G447S0T1VC"], "rxcui": ["313564", "313565"], "spl_set_id": ["c33a2a36-16d3-4a35-e053-2995a90af240"], "manufacturer_name": ["TIME CAP LABORATORIES, INC."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (49483-690-03)", "package_ndc": "49483-690-03", "marketing_start_date": "20210714"}, {"sample": false, "description": "10 TABLET in 1 BLISTER PACK (49483-690-04)", "package_ndc": "49483-690-04", "marketing_start_date": "20210714"}, {"sample": false, "description": "42 TABLET in 1 BOTTLE (49483-690-41)", "package_ndc": "49483-690-41", "marketing_start_date": "20210714"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (49483-690-50)", "package_ndc": "49483-690-50", "marketing_start_date": "20210714"}], "brand_name": "Valacyclovir Hydrochloride", "product_id": "49483-690_c715d9f2-9fe1-0bdd-e053-2a95a90aecf2", "dosage_form": "TABLET", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "49483-690", "generic_name": "Valacyclovir Hydrochloride", "labeler_name": "TIME CAP LABORATORIES, INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Valacyclovir Hydrochloride", "active_ingredients": [{"name": "VALACYCLOVIR HYDROCHLORIDE", "strength": "500 mg/1"}], "application_number": "ANDA079012", "marketing_category": "ANDA", "marketing_start_date": "20210714", "listing_expiration_date": "20261231"}